PROCEPT BioRobotics (PRCT) Net Cash Flow (QoQ) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn |
| 10 | PROCEPT BioRobotics | 974.25 Mn | 728.61 Mn | 53.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -427.58% |
| Dec 31, 2025 | 8.18% |
| Sep 30, 2025 | 37.43% |
| Jun 30, 2025 | 23.12% |
| Mar 31, 2025 | -112.79% |
| Dec 31, 2024 | 890.28% |
| Sep 30, 2024 | -50.93% |
| Jun 30, 2024 | 63.71% |
| Mar 31, 2024 | -3.28% |
| Dec 31, 2023 | -122.30% |
| Sep 30, 2023 | 539.23% |
| Jun 30, 2023 | 23.49% |
| Mar 31, 2023 | -49.45% |
| Dec 31, 2022 | -32.88% |
| Sep 30, 2022 | -42.16% |
| Jun 30, 2022 | 14.79% |
| Mar 31, 2022 | -5.14% |
| Dec 31, 2021 | -110.02% |
| Sep 30, 2021 | 120.58% |
| Jun 30, 2021 | 621.74% |